Bal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083D01012
  • NSEID: BALPHARMA
  • BSEID: 524824
INR
73.04
-1.53 (-2.05%)
BSENSE

Dec 05

BSE+NSE Vol: 230

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryBal Pharma VS Pharmaceuticals & Biotechnology
 
1D
-2.05%
-0.04%
1W
-4.31%
-0.55%
1M
-10.38%
2.13%
YTD
-40.25%
9.08%
1Y
-40.13%
4.24%
3Y
-18.39%
35.65%
5Y
33.65%
89.07%
10Y
-49.03%
232.45%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.61%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.42%
1.33%
-16.09%
6 Months
-26.74%
1.19%
-25.55%
1 Year
-40.13%
1.00%
-39.13%
2 Years
-31.22%
2.28%
-28.94%
3 Years
-18.39%
3.42%
-14.97%
4 Years
-25.32%
4.39%
-20.93%
5 Years
33.65%
9.60%
43.25%

Latest dividend: 1.2 per share ex-dividend date: Sep-18-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Underperformer

Bal Pharma Ltd has been in the Third and Fourth Quartile in the YTD and longer periods

3
Quartile
quartile-3
QTD
-10.13%
4
Quartile
quartile-4
Jun-Sep
-18.29%
2
Quartile
quartile-2
Mar-Jun
22.35%
3
Quartile
quartile-3
YTD
-38.88%
3
Quartile
quartile-3
2024
21.64%
4
Quartile
quartile-4
2023
10.2%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Underperformer

Bal Pharma Ltd has been in the Third and Fourth Quartile in the YTD and longer periods

3
Quartile
quartile-3
QTD
-10.13%
4
Quartile
quartile-4
Jun-Sep
-18.29%
2
Quartile
quartile-2
Mar-Jun
22.35%
4
Quartile
quartile-4
YTD
-38.88%
3
Quartile
quartile-3
2024
21.64%
3
Quartile
quartile-3
2023
10.2%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Bal Pharma Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-10.13%
4
Quartile
quartile-4
Jun-Sep
-18.29%
2
Quartile
quartile-2
Mar-Jun
22.35%
4
Quartile
quartile-4
YTD
-38.88%
2
Quartile
quartile-2
2024
21.64%
3
Quartile
quartile-3
2023
10.2%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available